DK0787807T3 - Primere og prober til detektion af hepatitis C - Google Patents

Primere og prober til detektion af hepatitis C

Info

Publication number
DK0787807T3
DK0787807T3 DK97106534T DK97106534T DK0787807T3 DK 0787807 T3 DK0787807 T3 DK 0787807T3 DK 97106534 T DK97106534 T DK 97106534T DK 97106534 T DK97106534 T DK 97106534T DK 0787807 T3 DK0787807 T3 DK 0787807T3
Authority
DK
Denmark
Prior art keywords
nucleic acids
hepatitis
probes
primers
amplifying
Prior art date
Application number
DK97106534T
Other languages
English (en)
Inventor
Robert M Resnick
Karen K Y Young
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27115393&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0787807(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0787807T3 publication Critical patent/DK0787807T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Paints Or Removers (AREA)
DK97106534T 1991-08-27 1992-08-19 Primere og prober til detektion af hepatitis C DK0787807T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75130591A 1991-08-27 1991-08-27
US91884492A 1992-07-21 1992-07-21

Publications (1)

Publication Number Publication Date
DK0787807T3 true DK0787807T3 (da) 2003-08-11

Family

ID=27115393

Family Applications (2)

Application Number Title Priority Date Filing Date
DK92114115T DK0529493T3 (da) 1991-08-27 1992-08-19 Fremgangsmåder og reagenser til hepatitis C-detektion
DK97106534T DK0787807T3 (da) 1991-08-27 1992-08-19 Primere og prober til detektion af hepatitis C

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK92114115T DK0529493T3 (da) 1991-08-27 1992-08-19 Fremgangsmåder og reagenser til hepatitis C-detektion

Country Status (18)

Country Link
US (2) US5527669A (da)
EP (2) EP0787807B1 (da)
JP (2) JP3790274B2 (da)
KR (1) KR100280758B1 (da)
CN (2) CN1047630C (da)
AT (2) ATE161291T1 (da)
AU (1) AU665952B2 (da)
CA (1) CA2076793C (da)
DE (2) DE69233083T2 (da)
DK (2) DK0529493T3 (da)
ES (2) ES2111589T3 (da)
FI (1) FI108731B (da)
GR (1) GR3026312T3 (da)
HK (1) HK1027868A1 (da)
IL (1) IL102896A (da)
NO (1) NO311730B1 (da)
NZ (1) NZ244071A (da)
PT (1) PT787807E (da)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639594A (en) * 1990-02-16 1997-06-17 United Biomedical, Inc. Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5582968A (en) * 1990-02-16 1996-12-10 United Biomedical, Inc. Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
JP3368902B2 (ja) * 1992-03-02 2003-01-20 カイロン エセ．ピー．アー． ワクチンおよび診断に有用なＨｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉタンパク質
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
JP4637972B2 (ja) * 1992-09-28 2011-02-23 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Ｈｃｖタンパク質の翻訳を制御するための方法および組成物
US5846704A (en) 1992-11-27 1998-12-08 N.V. Innogenetics S.A. Process for typing of HCV isolates
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
PL175360B1 (pl) * 1993-05-10 1998-12-31 Chiron Corp Cząsteczka kwasu nukleinowego i kompozycja do wykrywania infekcji wirusa zapalenia wątroby typu C
DE69428167T2 (de) * 1993-07-01 2002-05-29 F. Hoffmann-La Roche Ag, Basel Reagenz und Verfahren für reverse Transkription bei hoher Temperatur, verbunden mit einer Polymerase-Kettenreaktion
US6586568B1 (en) 1994-02-14 2003-07-01 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US5981172A (en) * 1994-02-14 1999-11-09 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use
US6451578B1 (en) 1994-02-14 2002-09-17 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6720166B2 (en) 1994-02-14 2004-04-13 Abbott Laboratories Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use
US6558898B1 (en) 1994-02-14 2003-05-06 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6051374A (en) * 1994-02-14 2000-04-18 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US5843450A (en) * 1994-02-14 1998-12-01 Abbott Laboratories Hepatitis GB Virus synthetic peptides and uses thereof
US6156495A (en) * 1994-02-14 2000-12-05 Abbott Laboratories Hepatitis GB virus recombinant proteins and uses thereof
JPH10502365A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクタータンパク質およびワクチン
US5955318A (en) * 1995-08-14 1999-09-21 Abbott Laboratories Reagents and methods useful for controlling the translation of hepatitis GBV proteins
US5807670A (en) * 1995-08-14 1998-09-15 Abbott Laboratories Detection of hepatitis GB virus genotypes
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7235394B1 (en) 1995-08-29 2007-06-26 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5837442A (en) * 1995-11-29 1998-11-17 Roche Molecular Systems, Inc. Oligonucleotide primers for amplifying HCV nucleic acid
GB2324093A (en) * 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
US5759795A (en) * 1996-03-08 1998-06-02 Schering Corporation Assay for determining inhibitors of ATPase
IT1284847B1 (it) * 1996-06-07 1998-05-22 Sorin Biomedica Diagnostics Sp Procedimento per la rivelazione di acidi nucleici specifici di hcv
US5989873A (en) * 1996-09-24 1999-11-23 Vinayagamoorthy; Thuraiayah Method of detecting gene expression and/or of preventing such expression in cells
CU22642A1 (es) * 1996-12-12 2000-12-22 Ct Ingenieria Genetica Biotech Secuencia de adnc derivadas del genoma del virus de la hepatitis c y su uso
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US7049428B1 (en) * 1998-03-04 2006-05-23 Washington University HCV variants
US5849800A (en) * 1997-03-28 1998-12-15 The Penn State Research Foundation Use of amantadine for treatment of Hepatitis C
US6277571B1 (en) * 1997-10-03 2001-08-21 Virginia Commonwealth University Intellectual Property Foundation Sequential consensus region-directed amplification of known and novel members of gene families
EP1029084A2 (de) 1997-11-04 2000-08-23 Roche Diagnostics GmbH Spezifisches und sensitives nukleinsäurenachweisverfahren
DE19832050C2 (de) * 1998-07-16 2002-10-10 Biotest Pharma Gmbh Verfahren zum Nachweis von Hepatitis B- bzw. Hepatitis C-Virusgenomen in Plasmaproben und spezifische Primer
CA2245039A1 (en) * 1998-08-13 2000-02-13 Vito Scalia Primer-specific and mispair extension assay for identifying gene variation
US6300069B1 (en) * 1999-05-03 2001-10-09 Qiagen Gmbh Generation and amplification of nucleic acids from ribonucleic acids
EP1233976A4 (en) * 1999-11-17 2003-06-11 Jiuping Ji SIMULTANEOUS DETECTION OF HBV, HCV AND HIV IN PLASMA SAMPLES WITH THE AID OF A MULTIPLEX FIXING TEST
KR20020063123A (ko) * 2001-01-26 2002-08-01 (주)네오딘 알티 피시알에 의한 ｃ형 간염바이러스 검출을 위한 키트및 그 검출방법
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US20040121309A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in blood, bodily fluids, and bodily tissues
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US7718354B2 (en) 2001-03-02 2010-05-18 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples
US8073627B2 (en) * 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
JP2005506322A (ja) * 2001-08-31 2005-03-03 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉワクチン接種
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US6946245B2 (en) 2001-12-04 2005-09-20 Quest Diagnostics Investments Incorporated Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
GB0200526D0 (en) * 2002-01-11 2002-02-27 Science And Technology The Methods
CA2489895A1 (en) 2002-07-26 2004-02-05 Abbott Laboratories Method of detecting and quantifying hepatitis c virus
US20040024193A1 (en) 2002-07-26 2004-02-05 Williams Gregg T. Method of detecting and quantifying hepatitis C virus
EP1578399A4 (en) 2002-12-06 2007-11-28 Isis Pharmaceuticals Inc METHODS FOR RAPID IDENTIFICATION OF PATHOGENS IN HUMANS AND BEETS
WO2004094986A2 (en) * 2003-04-16 2004-11-04 Handylab, Inc. System and method for electrochemical detection of biological compounds
US8046171B2 (en) 2003-04-18 2011-10-25 Ibis Biosciences, Inc. Methods and apparatus for genetic evaluation
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7947450B2 (en) 2003-07-10 2011-05-24 Universite Libre De Bruxelles Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed
AU2003246669A1 (en) * 2003-07-10 2005-01-28 Universite Libre De Bruxelles Device, kit and method for pulsing biological samples with an agent and stabilising the sample so pulsed
ES2596753T3 (es) 2003-08-29 2017-01-11 Fujirebio Europe N.V. Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo
US20120122101A1 (en) 2003-09-11 2012-05-17 Rangarajan Sampath Compositions for use in identification of bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
CA2540858C (en) * 2003-10-14 2009-12-08 Intermune, Inc. Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
US8163895B2 (en) 2003-12-05 2012-04-24 Ibis Biosciences, Inc. Compositions for use in identification of orthopoxviruses
US7473773B2 (en) * 2004-01-07 2009-01-06 Third Wave Technologies, Inc. Determination of hepatitis C virus genotype
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US8119336B2 (en) 2004-03-03 2012-02-21 Ibis Biosciences, Inc. Compositions for use in identification of alphaviruses
WO2005117270A2 (en) 2004-05-24 2005-12-08 Isis Pharmaceuticals, Inc. Mass spectrometry with selective ion filtration by digital thresholding
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
US20060068396A1 (en) * 2004-09-24 2006-03-30 Kaohsiung Medical University Method for biochip detecting limited cells
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
CA2600184A1 (en) 2005-03-03 2006-09-08 Isis Pharmaceuticals, Inc. Compositions for use in identification of adventitious viruses
US8067208B2 (en) * 2005-06-30 2011-11-29 Roche Molecular Systems, Inc. Probes and methods for hepatitis C virus typing using multidimensional probe analysis
AU2006272776B2 (en) 2005-07-21 2012-01-19 Ibis Biosciences, Inc. Methods for rapid identification and quantitation of nucleic acid variants
US20090050492A1 (en) * 2005-08-02 2009-02-26 Board Of Trustees Of Michigan State University Nanoporous silicon-based electrochemical nucleic acid biosensor
US9149473B2 (en) 2006-09-14 2015-10-06 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
EP2126132B1 (en) 2007-02-23 2013-03-20 Ibis Biosciences, Inc. Methods for rapid foresnsic dna analysis
WO2009023358A2 (en) * 2007-05-25 2009-02-19 Ibis Biosciences, Inc. Compositions for use in identification of strains of hepatitis c virus
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
EP2344893B1 (en) 2008-09-16 2014-10-15 Ibis Biosciences, Inc. Microplate handling systems and methods
EP2347254A2 (en) 2008-09-16 2011-07-27 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
EP2349549B1 (en) 2008-09-16 2012-07-18 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, and system
KR20120101278A (ko) 2009-01-21 2012-09-13 버텍스 파마슈티칼스 인코포레이티드 Ｃ형 간염 바이러스 핵산을 증폭시키는 방법
EP2396803A4 (en) 2009-02-12 2016-10-26 Ibis Biosciences Inc IONIZATION PROBE ASSEMBLIES
WO2011008971A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Lift and mount apparatus
WO2011008972A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Systems for bioagent identification
ES2628739T3 (es) 2009-10-15 2017-08-03 Ibis Biosciences, Inc. Amplificación por desplazamiento múltiple
WO2012153153A1 (en) 2011-05-11 2012-11-15 Diagon Kft. Procedure for rapid determination of viruses using nucleic acid-based molecular diagnostics, and a kit for this purpose
US9422601B2 (en) 2011-12-15 2016-08-23 Samsung Electronics Co., Ltd. Method of determining a ratio of RNA species in a sample
EP2722397B1 (en) * 2012-10-18 2017-12-13 F. Hoffmann-La Roche AG Dual probe assay for the detection of heterogeneous amplicon populations
ES2640570T3 (es) * 2012-10-18 2017-11-03 F. Hoffmann-La Roche Ag Ensayo de doble sonda para la detección de VHC
CN105483283B (zh) * 2014-10-11 2019-01-18 上海仁度生物科技有限公司 丙型肝炎病毒hcv实时荧光核酸恒温扩增检测试剂盒
WO2017212023A1 (en) 2016-06-10 2017-12-14 Roche Diagnostics Gmbh Compositions and methods for detection of hepatitis c virus genotype 3
CN108018376B (zh) * 2016-10-31 2020-11-03 深圳华大因源医药科技有限公司 一种用于丙肝病毒分型和耐药位点检测的探针和方法
WO2019070854A1 (en) * 2017-10-03 2019-04-11 Abbott Molecular Inc. ASSAY FOR DETECTION OF HEPATITIS C VIRUS (HCV)
GB201819726D0 (en) * 2018-12-03 2019-01-16 Diagnostics For The Real World Ltd HCV detection

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DE3886363T3 (de) * 1987-11-18 2004-09-09 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville NANBV-Diagnostika
WO1990011089A1 (en) * 1989-03-17 1990-10-04 Chiron Corporation Nanbv diagnostics and vaccines
DE69033891T2 (de) * 1989-05-18 2002-08-29 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville NANBV-Diagnostika: Polynukleotide, geeignet für Reihenuntersuchungen auf Hepatitis C-Virus
DE4023458A1 (de) * 1989-08-31 1991-03-07 Kali Chemie Ag Neue hochalkalische proteasen
CA2065287C (en) * 1989-09-15 1999-12-21 Tatsuo Miyamura New hcv isolates
LU87861A1 (fr) * 1989-12-18 1991-10-08 Wellcome Found Agent viral
DK0506889T3 (da) * 1989-12-22 1997-09-22 Hoffmann La Roche Reverse transkriptaser ved høj temperatur
CA2044296A1 (en) * 1990-06-12 1991-12-13 Hiroaki Okamoto Oligonucleotide primers, and their application for high-fidelity detection of non-a, non-b hepatitis virus
EP0933426A1 (en) * 1990-06-25 1999-08-04 The Research Foundation for Microbial Diseases of Osaka University Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides
EP0468657A3 (en) * 1990-07-09 1992-02-05 Tonen Corporation Non-a non b hepatitis-specific antigen and its use in hepatitus diagnosis
ATE150086T1 (de) * 1990-07-11 1997-03-15 Shionogi & Co Cdns-sequenz und detektion des hepatitis c-virus
CZ282573B6 (cs) * 1990-08-10 1997-08-13 Chiron Corporation Způsob detekce HCV sekvence, souprava a reakční činidlo pro detekci HCV
CA2090335A1 (en) * 1990-08-25 1992-02-26 Suzanne Zebedee Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines
EP0485209A1 (en) * 1990-11-08 1992-05-13 Immuno Japan Inc. Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides

Also Published As

Publication number Publication date
DE69223562T2 (de) 1998-06-04
US5580718A (en) 1996-12-03
JPH0686700A (ja) 1994-03-29
FI923840A (fi) 1993-02-28
EP0787807A3 (en) 1998-04-01
CN1259670A (zh) 2000-07-12
IL102896A (en) 1997-11-20
KR100280758B1 (ko) 2001-04-02
EP0787807A2 (en) 1997-08-06
DE69233083D1 (de) 2003-07-03
DK0529493T3 (da) 1998-08-24
US5527669A (en) 1996-06-18
NO923341L (no) 1993-03-01
NO923341D0 (no) 1992-08-26
EP0787807B1 (en) 2003-05-28
ATE161291T1 (de) 1998-01-15
NZ244071A (en) 1995-01-27
IL102896A0 (en) 1993-01-31
EP0529493A2 (en) 1993-03-03
PT787807E (pt) 2003-08-29
ES2198514T3 (es) 2004-02-01
JP4164098B2 (ja) 2008-10-08
ES2111589T3 (es) 1998-03-16
FI108731B (fi) 2002-03-15
KR930004479A (en) 1993-03-22
CN1134666C (zh) 2004-01-14
EP0529493A3 (en) 1993-07-28
HK1027868A1 (en) 2001-01-23
JP2006180884A (ja) 2006-07-13
JP3790274B2 (ja) 2006-06-28
EP0529493B1 (en) 1997-12-17
CN1071512A (zh) 1993-04-28
AU665952B2 (en) 1996-01-25
DE69233083T2 (de) 2003-12-18
CA2076793C (en) 2006-11-21
AU2121992A (en) 1993-03-04
CN1047630C (zh) 1999-12-22
GR3026312T3 (en) 1998-06-30
CA2076793A1 (en) 1993-02-28
NO311730B1 (no) 2002-01-14
FI923840A0 (fi) 1992-08-27
DE69223562D1 (de) 1998-01-29
ATE241704T1 (de) 2003-06-15

Similar Documents

Publication Publication Date Title
DK0787807T3 (da) Primere og prober til detektion af hepatitis C
DK0776981T3 (da) Oligonucleotidprimere til amplifikation af HCV-nukleinsyre
DK1026262T3 (da) Oligonukleotidprimere til effektiv detektering af hepatitis C-virus (HCV) og fremgangsmåder til anvendelse deraf
ATE237698T1 (de) Primers und sonden zum nachweis von hiv
ATE282720T1 (de) Nukleinsäuresequenzen als primer und sonden zur amplifizierung und erkennung von allen hiv-1 subtypen
DK564089A (da) Fremgangsmaade og reagens til paavisning af humant papillomavirus og m-rna
ES2094178T3 (es) Secuencias nucleotidicas utiles como sondas especificas del tipo cebadores pct y sondas para la amplificacion y deteccion del virus del papiloma humano, y kits y procedimientos utilizados con este fin.
WO2002064842A3 (en) Quantitative epstein barr virus pcr rapid assay
ATE449194T1 (de) Oligonukleotide zur detektion von hepatitis b viren
SE9002060D0 (sv) A method of detecting an infection caused by a specific type of virus, primers, probes and a test kit
NO20000537D0 (no) Oligonukleotidprimere for effektiv reverstranskripsjon av Hepatitis C-virus (HCV) RNA og metoder for anvendelse derav